Close
  Indian J Med Microbiol
 

Figure 3: Real-time quantitative PCR analysis of TLR-2, 7, 8 in human PBMC samples depending on drug consumption and dietary supplements. (a, b, c) Non-significant relative mRNA expression of TLR-2, -7, -8 in accordance with the drug history groups described above. (d) Significant relative mRNA expression of TLR-2 in dietary supplements users compared with non-users (e, f) Non-significant relative mRNA expression of TLR-7, -8 in different supplement user's groups compared with non-users. Student t-test and One-way ANNOVA analysis were applied. TLR-2, Toll-like receptor-2; TLR-7, Toll-like receptor-7; TLR-8, Toll-like receptor-8; UC, ulcerative colitis; (*P < 0.05)

Figure 3: Real-time quantitative PCR analysis of <i>TLR-2, 7, 8</i> in human PBMC samples depending on drug consumption and dietary supplements. (a, b, c) Non-significant relative mRNA expression of <i>TLR-2, -7, -8</i> in accordance with the drug history groups described above. (d) Significant relative mRNA expression of <i>TLR-2</i> in dietary supplements users compared with non-users (e, f) Non-significant relative mRNA expression of <i>TLR-7, -8</i> in different supplement user's groups compared with non-users. Student <i>t</i>-test and One-way ANNOVA analysis were applied. TLR-2, Toll-like receptor-2; TLR-7, Toll-like receptor-7; TLR-8, Toll-like receptor-8; UC, ulcerative colitis; (*<i>P</i> < 0.05)